Wellington Management Group LLP Decreases Stock Holdings in Maximus, Inc. $MMS

Wellington Management Group LLP cut its stake in Maximus, Inc. (NYSE:MMS) by 25.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 215,834 shares of the health services provider’s stock after selling 74,807 shares during the period. Wellington Management Group LLP owned approximately 0.41% of Maximus worth $11,603,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in MMS. BlackRock Inc. acquired a new position in Maximus during the second quarter worth $400,186,000. Dimensional Fund Advisors LP increased its stake in shares of Maximus by 7.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock worth $135,084,000 after acquiring an additional 141,362 shares during the last quarter. Reinhart Partners LLC. raised its holdings in shares of Maximus by 131.8% during the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock worth $106,575,000 after acquiring an additional 1,127,346 shares during the period. Geode Capital Management LLC raised its holdings in shares of Maximus by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock worth $127,952,000 after acquiring an additional 5,130 shares during the period. Finally, Van Berkom & Associates Inc. boosted its position in shares of Maximus by 3.7% during the 1st quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider’s stock valued at $75,137,000 after acquiring an additional 41,862 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE:MMS opened at $57.56 on Tuesday. Maximus, Inc. has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The company has a 50 day moving average price of $57.97 and a 200 day moving average price of $62.82. The stock has a market capitalization of $3.01 billion, a P/E ratio of 8.50 and a beta of 0.59.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the previous year, the company earned $2.16 earnings per share. The firm’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities research analysts forecast that Maximus, Inc. will post 8.03 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.32 annualized dividend and a yield of 2.3%. Maximus’s dividend payout ratio is presently 19.50%.

Analyst Ratings Changes

MMS has been the subject of several recent analyst reports. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Zacks Research lowered shares of Maximus from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a report on Monday, August 17th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.